Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RELEASE-2: Qwo for Cellulite
NCT03446781Phase 3Completed
- Sponsor
- Endo International plc
- Start
- Feb 2018
- Primary completion
- Sep 2018
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cellulite comparing EN3835 Active with Placebo (2 arms). Primary endpoint: 2-level Composite Responders for the Target Buttock at Day 71. Started Feb 2018; status: completed.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
cellulite
Beyond the preview
Go deeper on NCT03446781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03446781.